Detection Kits & Sample-prep
As a high-tech enterprise founded in 2018 by top epigenetic experts, Epiprobe focuses on the molecular diagnosis of cancer DNA methylation and precision theranostics industry. With a profound technology basis, we aim to lead the era of new products to nip cancer in the bud!
Based on Epiprobe core team’s long-term research, development and transformation in the field of DNA methylation with the cutting-edge innovations, combined with the unique DNA methylation targets of cancers, we use a unique multivariate algorithm combining big data and artificial intelligence technology to independently develop an exclusive patent-protected liquid biopsy technology.
Worldwide Exclusive: Tumor Aligned General Methylated EpiprobeMore
Build a cancer-free world
Convince with products
Keep everyone away from cancer
Covering the whole process of cancer theranostics
Latest news of Epiprobe